NCT02903784

Brief Summary

According to the O.M.S. Classification, grade 2 glioma is a pre-cancerous lesion, slowly progressive, infiltrating the central nervous system, mainly affecting young adults. This surgery should nevertheless be conducted in awake condition to achieve two conflicting goals: get maximum brain tissue infiltrated by the tumor while preserving the integrity of functional structures. So awake after opening the skull, the patient undergoes a series of preoperative tests, administered by a speech therapist present in the operating room. This procedure allows the neurosurgeon to establish an individual functional brain mapping in real time, through the observation by the SLP of the patient's answers to direct electrical stimulation applied to the cortical and sub-cortical. This support is based on the extraordinary plasticity demonstrated by the brain in the presence of a slowly progressive lesion. To ensure the patient the highest achievable load should increase our understanding of brain function, including the neural bases of language, glioma grade 2 is predominantly localized functional area of language.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
63

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2012

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2012

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2015

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

September 13, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 16, 2016

Completed
Last Updated

September 2, 2020

Status Verified

May 1, 2011

Enrollment Period

2.4 years

First QC Date

September 13, 2016

Last Update Submit

September 1, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • functional score

    The intraoperative testing is performed by an evaluator (speech / neuropsychologist), present in the operating room, the patient's side. Its role is to identify functional disturbances induced by direct electrical stimulation. To do this, two standardized tests are administered to the patient alternately for the duration of the awake period. These tests are presented on a computer screen in PowerPoint format, with a picture every four seconds.

    1 day

Secondary Outcomes (6)

  • Evaluation orthophonic

    1 day

  • Evaluation orthophonic

    5 day

  • Evaluation orthophonic

    3 month

  • Imagery Data

    1 day

  • Imagery Data

    5 day

  • +1 more secondary outcomes

Study Arms (2)

grade 2 glioma

OTHER

Patient with grade 2 glioma use a neuropsychological examination and brain imaging (fMRI and tractography)

Device: fMRIProcedure: tractographyOther: neuropsychological examination

healthy volunteers

OTHER

healthy volunteers use a neuropsychological examination and brain imaging (fMRI and tractography)

Device: fMRIProcedure: tractographyOther: neuropsychological examination

Interventions

fMRIDEVICE

Patient with grade 2 glioma and healthy volunteers use a brain imaging (fMRI)

grade 2 gliomahealthy volunteers
tractographyPROCEDURE

Patient with grade 2 glioma and healthy volunteers use a brain imaging (tractography)

grade 2 gliomahealthy volunteers

Patient with grade 2 glioma and healthy volunteers use a neuropsychological examination

grade 2 gliomahealthy volunteers

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients carry a grade glioma 2 functional area of language and presenting the information to receive surgical care provided in awake for the first time.
  • or Healthy volunteers will be selected using a matching age and sex of patients in the study (matched to a patient on two of the first forty patients).

You may not qualify if:

  • Subject presenting cons-indications to MRI (ventricular shunt valve, ferromagnetic foreign bodies, pacemaker, implantable defibrillators, cochlear hearing implant, claustrophobia, ....)
  • History of head trauma, ischemic stroke or intracerebral hematoma.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

AstrocytomaOligodendroglioma

Interventions

Magnetic Resonance ImagingDiffusion Tensor ImagingNeuropsychological Tests

Condition Hierarchy (Ancestors)

GliomaNeoplasms, NeuroepithelialNeuroectodermal TumorsNeoplasms, Germ Cell and EmbryonalNeoplasms by Histologic TypeNeoplasmsNeoplasms, Glandular and EpithelialNeoplasms, Nerve Tissue

Intervention Hierarchy (Ancestors)

TomographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisNeuroimagingDiffusion Magnetic Resonance ImagingDiagnostic Techniques, NeurologicalInvestigative TechniquesPsychological TestsBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 13, 2016

First Posted

September 16, 2016

Study Start

September 1, 2012

Primary Completion

February 1, 2015

Study Completion

September 1, 2016

Last Updated

September 2, 2020

Record last verified: 2011-05